DG 14
Goal: Medicines Expertise

Combination analgesic formulations for pain relief

DG 18 DG 14 DG 19 July 2025

Combination analgesic formulations for pain relief
Combination analgesic formulations for pain relief

Management of long-lasting musculoskeletal pain

DG 15 DG 9 DG 14 DG 19 November 2024

Management of long-lasting musculoskeletal pain
Management of long-lasting musculoskeletal pain

Managing period pain in the community pharmacy

DG 15 DG 9 DG 14 DG 19 November 2024

Episode 1: Primary dysmenorrhea 
Episode 1: Primary dysmenorrhea 
Episode 2: Secondary dysmenorrhea
Episode 2: Secondary dysmenorrhea

Paediatric pain and fever management

DG 15 DG 9 DG 14 DG 19 September 2024

Episode 1: Understanding paediatric pain and fever
Episode 1: Understanding paediatric pain and fever
Episode 2: Managing pain and fever across age groups
Episode 2: Managing pain and fever across age groups
Episode 3: Practical strategies and case scenarios for supporting care across age transitions in children
Episode 3: Practical strategies and case scenarios for supporting care across age transitions in children

Self-care approaches for fatty liver disease management

DG 15 DG 9 DG 14 DG 19 April 2024

Episode 1 – What is fatty liver disease and who is most at risk of developing it? 
Episode 1 – What is fatty liver disease and who is most at risk of developing it? 
Episode 2 – How can pharmacists support individuals living with fatty liver disease?
Episode 2 – How can pharmacists support individuals living with fatty liver disease?
Episode 2 – How can pharmacists support individuals living with fatty liver disease?
Episode 2 – How can pharmacists support individuals living with fatty liver disease?
Episode 2 – How can pharmacists support individuals living with fatty liver disease?
Episode 2 – How can pharmacists support individuals living with fatty liver disease?
Episode 3 – How can pharmacists support patients with co-morbidities in preventing fatty liver disease?
Episode 3 – How can pharmacists support patients with co-morbidities in preventing fatty liver disease?
Episode 3 – How can pharmacists support patients with co-morbidities in preventing fatty liver disease?
Episode 3 – How can pharmacists support patients with co-morbidities in preventing fatty liver disease?
Episode 3 – How can pharmacists support patients with co-morbidities in preventing fatty liver disease?
Episode 3 – How can pharmacists support patients with co-morbidities in preventing fatty liver disease?

Addressing vaccine fatigue, complacency and confidence

DG 9 DG 14 February 2024

Episode 1 – What can pharmacists in low- and middle-income countries do about adult vaccination mistrust?
Episode 1 – What can pharmacists in low- and middle-income countries do about adult vaccination mistrust?
Episode 2 – What is vaccine complacency and fatigue and how can pharmacists address them among at-risk adults?
Episode 2 – What is vaccine complacency and fatigue and how can pharmacists address them among at-risk adults?
Episode 3 – How can pharmacists build confidence in adult vaccination?
Episode 3 – How can pharmacists build confidence in adult vaccination?

The initiative is supported by